The COVID-19 vaccine candidates are based on human or simian adenoviral vectors and aim at eliciting a protective immune response of the recipient by delivering to cells the sequence of the antigenic SARS-CoV-2 S protein alone or combined with the N protein sequence. The gene discussed is PROS1; the disease is COVID-19.